ADAG
Price
$3.57
Change
-$0.01 (-0.28%)
Updated
Jun 12 closing price
Capitalization
235.88M
80 days until earnings call
Intraday BUY SELL Signals
LENZ
Price
$6.77
Change
+$0.27 (+4.15%)
Updated
Jun 12 closing price
Capitalization
212.27M
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADAG vs LENZ

Header iconADAG vs LENZ Comparison
Open Charts ADAG vs LENZBanner chart's image
ADAG vs LENZ Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADAG vs. LENZ commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAG is a Hold and LENZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2026
Stock price -- (ADAG: $3.57 vs. LENZ: $6.77)
Brand notoriety: ADAG and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAG: 118% vs. LENZ: 37%
Market capitalization -- ADAG: $235.88M vs. LENZ: $212.27M
ADAG [@Biotechnology] is valued at $235.88M. LENZ’s [@Biotechnology] market capitalization is $212.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $112.92B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAG’s FA Score shows that 0 FA rating(s) are green whileLENZ’s FA Score has 1 green FA rating(s).

  • ADAG’s FA Score: 0 green, 5 red.
  • LENZ’s FA Score: 1 green, 4 red.
According to our system of comparison, ADAG is a better buy in the long-term than LENZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAG’s TA Score shows that 2 TA indicator(s) are bullish while LENZ’s TA Score has 5 bullish TA indicator(s).

  • ADAG’s TA Score: 2 bullish, 6 bearish.
  • LENZ’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LENZ is a better buy in the short-term than ADAG.

Price Growth

ADAG (@Biotechnology) experienced а +7.53% price change this week, while LENZ (@Biotechnology) price change was -3.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +90.18%, and the average quarterly price growth was +2050.65%.

Reported Earning Dates

ADAG is expected to report earnings on Sep 02, 2026.

LENZ is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+0.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADAG($236M) has a higher market cap than LENZ($212M). ADAG YTD gains are higher at: 88.889 vs. LENZ (-57.687). ADAG has higher annual earnings (EBITDA): -29.17M vs. LENZ (-117.98M). LENZ has more cash in the bank: 258M vs. ADAG (62.8M). LENZ has less debt than ADAG: LENZ (673K) vs ADAG (6.85M). LENZ has higher revenues than ADAG: LENZ (21M) vs ADAG (103K).
ADAGLENZADAG / LENZ
Capitalization236M212M111%
EBITDA-29.17M-117.98M25%
Gain YTD88.889-57.687-154%
P/E RatioN/A48.03-
Revenue103K21M0%
Total Cash62.8M258M24%
Total Debt6.85M673K1,018%
TECHNICAL ANALYSIS
Technical Analysis
ADAGLENZ
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 20 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ADAG
Daily Signal:
Gain/Loss:
LENZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NPNRX60.830.73
+1.21%
Neuberger Large Cap Value R3
FTCEX16.780.12
+0.72%
Fidelity Advisor Total Intl Equity C
SFECX28.370.20
+0.71%
NAA Large Core C
NWJFX148.320.93
+0.63%
Nationwide NYSE Arca Tech 100 Idx InsSvc
NCAVX13.33N/A
N/A
Nuance Concentrated Value Investor

ADAG and

Correlation & Price change

A.I.dvisor tells us that ADAG and QCLS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADAG and QCLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAG
1D Price
Change %
ADAG100%
-0.28%
QCLS - ADAG
26%
Poorly correlated
+1.31%
ABOS - ADAG
25%
Poorly correlated
N/A
GERN - ADAG
24%
Poorly correlated
+0.88%
IBO - ADAG
23%
Poorly correlated
+4.46%
LENZ - ADAG
23%
Poorly correlated
+4.15%
More